UNSPSC 85815724: Introduction of other antineoplastic into central vein, percutaneous approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of other antineoplastic into central vein, percutaneous approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E04305

UNSPSC 85815724 Introduction of other antineoplastic into central vein, percutaneous approach is a Commodity code that bears little relationship to the state and local procurement activity present in the recent-opportunities block. The code nominally describes a medical procedure—chemotherapy drug administration via central venous catheter—yet the recent solicitations tagged to this code span virtual urgent care platforms, PACE (Program of All Inclusive Care for the Elderly) operations, cancer registry services, medical directorships, employee wellness programs, occupational health services, opioid treatment and recovery initiatives, and behavioral health crisis stabilization. This mismatch signals either a taxonomy classification error or stale metadata; state and local procurement offices do not regularly solicit for in-vivo antineoplastic infusion as a standalone commodity, and the recent activity shows no chemotherapy-administration contracts. The code shows little decision-relevant recent activity directly aligned with its stated scope.

The issuing bodies soliciting under codes tagged to this block span state health authorities (Nevada), county health systems (Santa Clara, DeKalb, Brevard), municipal governments (Phoenix, Ocala, Atlanta, Sarasota), public school districts (Parkway), regional health planning entities (Inland Empire Health Plan), and behavioral health and human services departments (Colorado, Texas, Rockland County, Fairfax County, Sedgwick County). Geographic concentration across recent opportunities includes California, Georgia, Florida, Colorado, Kansas, and Nevada, with additional scattered activity across Texas, Oregon, Missouri, and other states. Representative recent opportunities include the Nevada Health Authority's RFP 41NHA-S4038 for PACE operations across Nevada (proposals due December 10, 2026), San Mateo County's RFP for Cancer Registry Services (proposals due November 6, 2026), the City of Phoenix's cancer screening services procurement (proposals due February 2, 2026), and Sedgwick County's paired RFPs for opioid use disorder treatment and prevention services funded by opioid settlement proceeds (proposals due September 15, 2026). The code's nominal scope does not meaningfully frame these opportunities, and business development professionals should verify code accuracy through the issuing authority before investing pursuit resources.